Figure 1From: Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin) Change in Prolactin Levels over 8 weeks in a Double Blind Trial: Aripiprazole vs. Placebo. Back to article page